Post-transplantation B cell function in different molecular types of SCID
about
B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiencyHuman lymphoid development in the absence of common γ-chain receptor signaling.Transplantation outcomes for severe combined immunodeficiency, 2000-2009.Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.Hematopoietic stem cell transplantation for primary immunodeficiencies.Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?Long-term outcome of non-ablative booster BMT in patients with SCIDThe natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901.Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.Survey on retransplantation criteria for patients with severe combined immunodeficiency.Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.Diagnostic Immunization with Bacteriophage ΦX 174 in Patients with Common Variable Immunodeficiency/Hypogammaglobulinemia.Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsoRecommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsortiumCytokine-Mediated Regulation of Human Lymphocyte Development and Function: Insights from Primary Immunodeficiencies.Haematopoietic stem cell transplantation for severe combined immunodeficiency: Long-term health outcomes and patient perspectives.Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.Unconditioned unrelated donor bone marrow transplantation for IL7Rα- and Artemis-deficient SCID.Long term outcomes of severe combined immunodeficiency: therapy implications.Efficacy of lentiviral mediated gene therapy in an Omenn syndrome Rag2 mouse model is not hindered by inflammation and immune dysregulation.Severe combined immunodeficiencies and related disorders.B cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency.
P2860
Q26828763-6A7EC53B-1448-4E40-B009-8F735A563312Q33434039-671893C6-74DE-4A42-ABD2-C3B3B3441F8BQ33722772-130AC6BF-7CE0-4B71-8FD6-C9E5083888E0Q33736960-F4324627-2AD1-41ED-AC8D-CBA37A014E24Q34279715-57D49125-F273-4502-A9C2-680CC37BDBAFQ34294647-A90E133B-DFBE-4601-9071-40F2B8297A40Q34630754-8882FA0F-50D1-4EEE-996B-DE8603023ACAQ36269199-07057FB7-747F-435C-8D03-673E1431513CQ37079714-765172DA-723C-4B83-931E-A6E6C481736BQ37201035-D41D531A-BEC6-41C0-9B18-966BFB325C4BQ37618790-D9D24FD6-7376-4CA9-B08B-7E99A6885D3FQ37649786-23215822-2DD6-4B5F-BA93-D813DE53AC22Q37664729-5732CD6C-CA3D-46C8-826B-76CF9ACBE557Q38249185-AEE03142-1E31-4CD3-9096-BF9BFAA4ACEDQ38772827-D78E4A60-C78C-4A17-9037-025031F5C9F8Q39289010-0D6BA26D-2511-49F7-B673-37D6D7CAEA2EQ40065888-B9DE9AF3-C9BB-4C2C-8DCC-8583BC54D60DQ40209304-F4D9B625-2138-410D-A0B4-0449C1FC3F40Q41070585-5A3ED7EE-1C40-4D3D-8FA1-ABDCB1686DC7Q44575275-AEC0BCA6-20DB-4683-BA27-954DB648574EQ45872036-61A4F040-2ED0-49DF-9570-C0107DD6F6A9Q45875844-3A813E53-084B-4C1E-A749-D0872C3815F5Q45886049-97ADF549-13D7-4EF8-B150-36F6DF6E22C4Q53819932-E46216C8-83C5-44A4-867D-359DAD0A07D9Q55334301-D2CEF5A4-49E4-4D06-9C85-6E518FD84E90
P2860
Post-transplantation B cell function in different molecular types of SCID
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Post-transplantation B cell function in different molecular types of SCID
@ast
Post-transplantation B cell function in different molecular types of SCID
@en
type
label
Post-transplantation B cell function in different molecular types of SCID
@ast
Post-transplantation B cell function in different molecular types of SCID
@en
prefLabel
Post-transplantation B cell function in different molecular types of SCID
@ast
Post-transplantation B cell function in different molecular types of SCID
@en
P2093
P2860
P1476
Post-transplantation B cell function in different molecular types of SCID
@en
P2093
Barry K Moser
Chan M Win
Elisa Sajaroff
Marcella Sarzotti-Kelsoe
Rebecca H Buckley
Roberta E Parrott
P2860
P2888
P304
P356
10.1007/S10875-012-9797-6
P577
2012-09-22T00:00:00Z